IN REVIEW

The Neurobiology, Neuropharmacology, and Pharmacological Treatment of the Paraphilias and Compulsive Sexual Behaviour
John MW Brad ford, MB, ChB, DPM, FF Psych, FRC Psych, DABPN, DABFP, FRCPC1

There has been in creas ing in ter est in the treat ment of sex ual dis or ders in re cent years. Sex ual dis or ders are clas si fied in DSM-IV as sex ual dysfunctions, paraphilias, and gen der iden tity dis or ders. The sex ual dysfunctions are nondeviant or nonparaphillic. The sex ual dys func tion dis or ders should in clude “hy per ac tive sex ual de sire dis or der” un der sex ual de sire dis or ders . Fur ther, there should be a speci fier for paraphilias of “with hypersexuality” or “with out hypersexuality. ” There is still in com plete un derstand ing of the neurobiology of sex ual dis or ders al though func tional neuroanatomy and neoropharmcological re search has exposed the neurotransmitters, receptors, and hormones that are in volved in sex ual de sire. Various pharmacological agents in clud ing se ro to nin reuptake in hib i tors, antiandrogens, LHRH agonists, and oth ers have been doc u mented as re duc ing sex ual de sire. An al go rithm for the use of these drugs in the treat ment of the paraphilias as well nonparaphilic hypersexuality is out lined. The modes of ac tion, dos ages, aims of treat ment, and usual meth ods of pre scrib ing these agent s is re viewed in this ar ti cle. Some fu ture di rec tions of re search in phar ma co log i cal treat ment is also dis cussed. (Can J Psy chi a try 2001;46:26– 34) Key Words: sexual desire disorders, paraphilias, hypersexuality, compulsive sexual behaviour, antiandrogens, specific serotonin reuptake inhibitors, LHRH agonists

A

l though it would be pre ma ture to say that the neurobiology and neuropharmacology of sex ual be haviour is un der stood, there clearly have been ma jor ad vances in re cent years. There has been sig nif i cant re search on the se rotonin receptors and their function in the brain. Serotonin (5-HT) is in volved in the neurobiology of many psy chi at ric dis or ders, par tic u larly mood disorder, and specifically de pres sion, anx i ety, schizo phre nia, eat ing dis or ders, and ob sessive–compulsive dis order (OCD). It also plays a role in mi graines. Al though the eti ol ogy of these dis or ders is not under stood, phar ma co log i cal treat ments that mod u late lev els of 5-HT have shown to be ef fec tive in all of them. Fur ther, sexual disor ders, both paraphilic (sexual devi a tion) and nonparaphilic (com pul sive sex ual dis or der or nonparaphilic hypersexuality), have also responded to pharmacological treat ments mod u lat ing se ro to nin lev els (1). This has led to the spec u la tion that a group of dis or ders could be clas si fied together as obsessive–compulsive spectrum disorders (1,2). This is based not only on the diagnostic characteristics of these dis or ders as out lined in DSM-IV but also on the fact that

they respond to pharmacological treatment af fecting the cen tral ner vous sys tem level of 5-HT (1,2). In gen eral, the as sess ment and treat ment of all types of sex ual dis or ders have been ne glected by psy chi a try. In re cent years, how ever, ad vances in psy chi at ric re search have fo cused gen eral psychiatry on these important clinical entities. OCD spec trum dis or ders in clude OCD, eat ing dis or ders, somatoform dis or ders, im pulse con trol dis or ders, and neu ro psychiatric dis or ders such as Tourette syn drome (TS); they may also in clude the sex ual dis or ders (1,2). There are clin i cal sim i lar i ties be tween OCD and sex ual dis or ders that can be sum ma rized as fol lows (1):
· Ob ses sions are sim i lar to sex ual fan ta sies, both paraphilic

and nonparaphilic.
· Com pul sions are sim i lar to com pul sive sex ual be hav iour

(CSB), which can be paraphilic or nonparaphilic.
· There is a cross over of comorbidity be tween OCD and the

sex ual dis or ders, with de pres sion and anx i ety dis or ders being com mon in both groups.
· At a neurobiological and neuropharmacological level,

Manu script re ceived and ac cepted De cem ber, 2000.
1 Pro fes sor and Head, Di vi sion of Fo ren sic Psy chia try, Uni ver sity of Ot tawa;

there is a sig nif i cant over lap be tween these dis or ders. There is no con sensus at this time as to whether the paraphilias and com pul sive sex ual be hav iour (nonparaphilic hypersexuality) should be included in the OCD spectrum disorders.
26

Royal Ot tawa Hos pi tal, Ot tawa, On tario. Ad dress for cor re spon dence: Dr JMW Brad ford, Royal Ot tawa Hos pi tal, 1145 Car ling Ave nue, Ot tawa, On tario K1Z 7K4 e- mail: jbrad for@rohcg.on.ca

Can J Psy chia try, Vol 46, Feb ru ary 2001

and the sites of the le sions caus ing OCD over lap con sid er ably with the ones that are as so ci ated with sex ual dis or ders (5). Based on this work. Both nonparaphilic hyposexuality and hypersexuality have been reported in as so ci a tion with var i ous brain le sions. there would have to be some de gree of so cial or oc cu pa tional or other dys func tion cou pled with it. Paraphilic be hav iour has been reported secondary to a wide variety of neuropsychiatric dis or ders. have mostly nonselective ef fects on postsynaptic 5-HT re cep tor sub types (3). The cau tion here is that this is most likely part of a gen eral be hav ioural disinhibition rather than be ing spe cific to sex ual be hav iour. and multiple sclerosis (5). Phar ma co log i cal re search is es tab lish ing se lec tive lig ands for the var i ous recep tor sub types. rather than sim ply a quan ti ta tive mea sure of to tal or gasms per week. OCD has also been ob served sec ond ary to var i ous neu ro log i cal dis or ders. 5-HT 5A and 5-HT 5B. com pul sive use of por nog ra phy.7). how ever. paraphilia and CSB ap pear to be a be hav ioural re sponse to that ab nor mal ity. 5-HT2B . but 5-HT5 has 2 sub types. It is interesting that coprolalia and copropraxia in TS clearly have a sex ual be hav iour com po nent (8). while the av er age man would have 3 (9). No sub types have been iden ti fied for the 5-HT and 6 5-HT7 re cep tors (3). What is needed is a large study of paraphilic and nonparaphilic men and women in whom typ i cal pat terns of sex ual drive are ex am ined.February 2001 Treat ment of the Paraphilias and Com pul sive Sex ual Be hav iour 27 There has been con sid er able re cent prog ress in map ping out 5-HT receptor sub types (3). Since that time. The 5-HT 2 sys tem has been shown to have 5-HT A. 5-HT 1D. Var i ous sub types have also been iden ti fied. it does not de fine hypersexuality in em pir i cal terms. tu mours in var i ous sites.6. There has also been re search show ing that corticostriatal cir cuits are most likely in volved in OCD and TS (4. Neuropharmacological re search into 5-HT re cep tors is likely to con tinue to be of sig nif i cant in ter est to gen eral psy chi a try and to the eval u a tion and treat ment of sex ual dis or ders.5). The clin i cal pre sen ta tion of cer tain el derly pa tients with de men tia and disinhibited behav iour in clud ing paraphilic behav iour (ex hi bi tion ism) and nonparaphilic hypersexuality (in ap pro pri ate sex ual ad vances to women) is mostly re ported. Other re search shows that these symp toms are re lated to the de gree of Tourette syn drome gene-loading that is pres ent (7). spe cif ically 5-HT1F. and nonparaphilic hypersexuality (8).6. It is also pos si ble that other 5-HT recep tor sub types will be iso lated or that fur ther vari a tions in re cep tor sub types will be found. At the same time. The ini tial work on 5-HT re cep tor sub types was based on phar ma co log i cal tools. 5-HT1E. This will help elu ci date how 5-HT re cep tor sub types af fect be hav iour. and 5-HT4. In ter est ingly. The ex act na ture of hypersexuality is dif fi cult to de fine. septal le sions. includ ing sex ual dis or ders. bi lat eral temporal lobe les ions. but the lat ter have also led to the iden ti fi ca tion of “novel” 5-HT re cep tors. in my opin ion. TS. the re search lit er a ture shows that lesions in cer tain parts of the brain can lead to disinhibition of sex ual be hav iour that may re sult in com pul sive sex ual be haviour (3). 4 main sub groups of 5-HT re cep tors have been identified. there is pos si bly an over lap of the neurobiological ab nor mal ity and OCD spec trum dis or ders. These in clude tem po ral lobe ep i lepsy. 5-HT2 . 5-HT1B. and 5-HT 7 (3). is that there are some men who have hypersexuality. and 5-HT1F subtypes. A more de tailed clin i cal eval ua tion would usu ally show that this is more clin i cally ob vi ous disinhibited be hav iour among a spec trum of other disinhibited be hav iours (4. This clas si fi ca tion has been con firmed by the so phis ticated tech niques of mo lec u lar bi ol ogy. Testing for the pres ence or ab sence of paraphilia would be rep li cated at all levels of sexual drive. Al though this is sim ple and at trac tive in clin i cal terms. an ti de pres sants act ing presynaptically to serotonergic neurons. com mon sec ond mes sen ger cou pling. and func tional activity of ligands have iso lated fur ther re cep tor types (3). Perhaps mu ta tions of the 5-HT re cep tor or subreceptor struc tures will be found to play a r o l e i n a v a r i e t y of psy c h i a t r i c dis or d e r s ( 3 ) . spe cifically 5-HT1. It has also been noted that there is comorbidity be tween sex ual dis or ders and TS. facil i tat ing the de vel op ment of sub type-specific agonists and an tag o nists. 5-HT 3. com pul sive sex ual behav iour. These observations sup port a re la tion be tween paraphilic be hav iour. Broadly. Many phar ma co log i cal treatments act ing on the cen tral 5-HT sys tem. What is im por tant con cep tu ally. In ad di tion. All of the 5-HT re cep tors be long to a fam ily of G pro tein-coupled re cep tors (3). These in clude compul sive mas tur ba tion. there are ref er ences to disinhibited sex ual be hav iour as a result of fron tal lobe le sions. some of whom may be paraphilic and some who are not. is one mea sure o f hypersexuality. some in di vid u als ex hibit com pul sive sex ual behav iours (CSB) which are nonparaphilic. postencephalitic neu ro psy chi at ric syn dromes. as men and women who have a paraphilia may be hypersexual. and hypersexality. In ad di tion. such as se lec tive sero to nin reuptake in hib i tors (SSRIs). and a neurobiological ab normality. and . and 5-HT2C 2 sub types. Kafka has at tempted to ad dress this prob lem in a study of men pre sent ing for treat ment with com pul sive sex ual be hav iour. 5-HT 5. There do not yet ap pear to be any sub types of 5-HT 3 and 5-HT 4 re cep tors. The 5-HT1 re cep tor has 5-HT 1A. orig i nally de fined by Kinsey as the num ber of or gasms per week. Var i ous lev els of sex drive could be es tab lished and de fined as hyposexuality.7). 5-HT6. normosexuality. There have been several studies on the neurobiology of hypersexuality. In the neu ro log i cal and neu ro psy chi at ric lit er a ture. In di vid uals with PRD were found in a small study to have 5 or more sex ual out lets (or gasms) per week for long pe ri ods of their adult lives. fron tal lobe le sions. normosexual. which he de scribes as “paraphilia re lated dis or ders” (PRD) (9). based on ranges of sex ual out let mea sures. or hyposexual. in clud ing ex hi bi tion ism. The to tal sex ual out let (TSO). These sexual symp toms de crease with treat ment us ing SSRIs and dopamine blockers (4. and 5-HT receptor an tag o nists used in the pro phy laxis of mi graine. other paraphilias. re cep tor bind ing profiles.

Studies of hor mone re place ment in hypogonadal men as well as stud ies of the ef fects of hor mone lev els in men with sex ual dys func tion have all con trib uted to our knowl edge of the role of an dro gens in male sex ual be hav iour (11). and the ad re nal glands (10). Aromatization oc curs in the hy po thal a mus and else where and is also re lated to sex ual drive in hu mans (11). Hypersexuality would be rec og nized as dis tinct from CSB and paraphilic behav iour. can have very sig nif i cant and last ing ef fects on sex ual be hav iour (1. rang ing in size from 2 to about 40 amino ac ids. ma nip u la tions of 5-HT and do pa mine can either decrease or increase sexual behaviour. A consis tent di ag nos tic for mu la tion for hypersexuality must be de vel oped. and the pe nis (11). the ac tual in ci dence and prev a lence of the paraphilias is un known (18. The hy po thalamic re gions con tain con sid er able amounts of these neuropeptides. Tes tos ter one can also be aromatized to estradiol. com pli cated mech a nisms both fa cil i tate and in hibit sex ual be hav iour and in volve all of these neurobiological systems—and prob a bly oth ers as well. in clud ing go nad o tro pin-releasing hor mone (GRH) and prolactin (10). How ever. The be hav ioural ef fects of the prin ci pal an dro gens in the hu man male. how ever. Thus. Al though re search in rats has shown that the ef fects of neuropeptides on sex ual be haviour are me di ated solely through cer tain se ro to nin re cep tor sub types (12). or hyposexual. is a chain of 2 or more amino ac ids linked by pep tide bonds and dif fers from other pro teins only in the na ture of the pep tide links (10). specifically in the septal area and hy po thal a mus. in con trast to normosexuality or hyposexuality. do pa mine but is also reg u lated by neuropeptide neurotransmitters. a m o n g o t h ers. tactile sen sitivity is androgen-dependent (11). and thyroid-releasing hor mone (TRH) (10). These neuropeptides are simi lar to monoamine neurotransmitters in having receptors on neu rons. Animal re search and clin i cal stud ies have shown that the monoamines 5-HT and dopamine affect sexual behaviour (1. Fur ther. In the spi nal cord. The etiology of the paraphilias or sex ual de vi a tions is unknown (17. corticotropin-releasing hor m o n e (CRH). as seen in cer tain prolactin-producing tu mours (11). As com pul sive sex ual be haviour be comes more de fined con cep tu ally and di ag nos ti cally. In ad di tion. can be achieved. No 1 pro mis cu ity. GRH stim u lates the re lease of fol li cle-stimulating hor mone (FSH) and luteinizing hormone (LH) from the pituitary. What is not clear from re search to date is whether hypersexuality is an ag gra vat ing fac tor in paraphilias. the role of the neuropeptide trans mit ter GRH is crit i cal to an un der stand ing of hu man sex ual be hav iour (11). are me di ated through T re cep tors and DHT re cep tors in the brain. One dif fer ence. by def i ni tion. The first el e ment that disappears is ejaculation. would be developed. These re sponses are re stored in the re verse se quence with an dro gen re place ment (11). to a lesser ex tent. which they can ex cite or in hibit (10).18). bi o log i cally ac tive pep tides. depending on which neuropharmacological intervention occurs (1. 14–16). lo cated prin ci pally in the hy po thal a mus. Neuropeptides are found through out the cen tral ner vous system as well as in pe riph eral or gans such as the gas tro in tes ti nal tract. the neurobiology of human sexual behaviour is extremely com pli cated and in volves not only the monoamine trans mit ters 5-HT and. whether nonparaphilic or paraphilic. the re flexes con trol ling erec tion and ejac u la tion are an dro gen-dependent and in the penis. Fur ther. In di vid uals with CSB may also be hypersexual.10). A neuropeptide. These are in the limbic sys tem of the brain. The sites of ac tion of an dro gens in the male an i mal are known to a cer tain de gree.19). A national sur vey in Can ada in 1984 found that 23. the pi tu itary. cir cu lat ing an dro gens and intracellular DHT and T receptors. normosexual. Over 100 unique.5 % of fe males . is that the rate of ac tiv ity for neuropeptides is slow com pared with that of the monoamine neurotransmitters. in clud ing. the spi nal cord. 24% of fe males had been vic tims of sex ual abuse when they were 14 years of age or youn ger (20). Studies of hyperprolactinemia show that it causes a de cline in sex ual de sire. by their actions on monoamine neurotransmitters and their ef fects on an dro gen re cep tors and cir cu lat ing hor mone lev els. G R H . the as sump tion that ei ther 5-HT or do pa mine independently have a dominant neurobiological role in controlling sexual be hav iour in hu mans is most likely completely in ac cu rate. Clearly. It is ob vi ous that these mechanisms are not fully understood at this time and it is there fore ex tremely pre ma ture to talk about a “monoamine hypothesis of compulsive sex ual be hav iour. As ini tially re ported by Kinsey in the late 1940s. certain pharmacological agents. The be havioural ef fects of neuropeptides have been ob served af ter their injection di rectly into the cen tral ner vous sys tem—the pre ferred method of ad min is tra tion be cause most of the pep tides can not pen e trate the blood-brain bar rier in amounts suf fi cient to be ac tive (10). What is known is that the level of vic tim iza tion of males and fe males in the gen eral pop u la tion is fairly con sis tent. Clearly. both an i mal re search and research on the hu man male have shown that sex ual be hav iour de clines fol low ing sur gi cal cas tra tion and that this oc curs at dif fer ent rates in dif fer ent spe cies. and the hy po thal a mus (11–13).28 The Ca na dian Jour nal of Psy chia try Vol 46. and then mount ing be hav iour (11). tes tos ter one (T) and dihydrotestosterone (DHT). the pan creas. have been found. followed by intromission. a spe cific pharmacological approach to hypersexuality (paraphilic or nonparaphilic).” At the same time.10). Any dis cus sion of the ef fects of neurobiology on sex ual behav iour has to take into ac count the neuropeptides in the brain that are significantly involved with the regulation of hor mones (10). and the du ra tion of their ac tiv ity can be ex tended for sub stan tially lon ger pe ri ods of time (10). also play a very im por tant role. which drive the pro duc tion of tes tos ter one in the tes tes and estro gen and other hor mones in the ova ries (11). and it should be in cluded in DSM-V. par tic u larly in the septal re gion. The sit u a tion in humans is much more com pli cated (11). A reduction in sexual behaviour.

ap prox i mately 35% were vic tims of sex ual abuse as children. The newly-developed algorithm encompasses 6 levels of treat ment for the 4 cat e go ries of paraphilia. Mod er ate 3. There are a num ber of phar ma co log i cal in ter ven tions that are avail able for the treat ment of CSB and the paraphilias. This would be used in mild and mod er ate lev els of paraphilia. Sex ual drive con sists of var i ous com po nents. spe cif ically. it is known that among iden tified pedophiles. As dis cussed later in this pa per. the pres ence of sex ual fan ta sies which may be nonparaphilic or paraphilic. This reg i men would be used in most mod er ate cases and in some se vere cases. Phar ma co log i cal agents have been iden ti fied that can af fect all of the com po nents of sex ual drive. how ever. us ing var i ous psy cho log i cal and phys i o log i cal tests. This sex hormone profile will also provide the base line for any treat ments in volv ing antiandrogens or hormones. has been added to the orig i nal 3 de scribed in DSM-III-R. Level 4: The full antiandrogen or hor monal treat ment would be given orally. FSH. these dis or ders would still have a vastly higher prevalence than most other psychiatric disorders. neuropsychiatric expertise should be avail able and should be used to com plete the eval u a tion. cat a strophic. Se vere 4. Ideally. there is typ i cally a de tailed psy chi at ric and phys i cal ex am i na tion and an as sess ment of sex ual be haviour. As the pres ence of de vi ant sex ual fan ta sies is an in di ca tion of the pres ence of a paraphilia at a mild level. and pro gesterone. one would want phar ma colog i cal agents that could af fect de vi ant sex ual in ter ests in the case of paraphilias but not af fect nondeviant sex ual be haviour. How ever. LH. the na ture and de gree of cog ni tive dis tor tions and how they re late to paraphilias. even if these fig ures were over es ti mated by a fac tor of 10. Cat a strophic The last cat e gory. The evaluation of sexual behaviour re quires ex per tise and training in sexology and a specialized sexual behaviours clinic.February 2001 Treat ment of the Paraphilias and Com pul sive Sex ual Be hav iour 29 and 12. The new clas si fi ca tion scheme has 4 cat e go ries (24): 1. Mild 2. these are gross overestimates of the prev alence of mild pedophilia and sex ual sa dism. Level 3: If the SSRIs were not ef fec tive in 4 to 6 weeks at ad equate dos age lev els. and the real lev els are 6% and 3%. and fi nally. It may there fore be pos si ble to es timate the prev a lence of pedophilia in the gen eral pop u la tion through extrapolation. The eval u a tion in cludes a sex hor mone pro file. This may assist in gaug ing the prev a lence of one paraphilia. cog nitive-behavioural treat ment and re lapse-prevention treat ment would al ways be given. In addition. In one study of sexual fantasies. The full ver sion of this clas si fi cation is avail able in a re cent pub li ca tion by this au thor (23). Level 2: Phar ma co log i cal treat ment would start with SSRIs. Level 1: Re gard less of the se ver ity of the paraphilia. two-thirds of males re ported het ero sex ual pedophilic fan tasies and about one-third of males had rape fan ta sies (22). the ac tual sex ual ac tiv ity it self. in clud ing a psy cho logi cal com po nent of sub jec tive de sire to en gage in sex ual ac tivity (the sex ual equiv a lent of hun ger). Var i ous ques tion naires are used to provide a struc tured sex ual his tory and mea sure the na ture and de gree of sex ual fan ta sies. In my opin ion. The average number of victims per pedophile is also known. a small dose of an antiandrogen would be added. Fur ther. this im plies that mild pedophilia is prev a lent at a stag ger ingly high rate in men in the gen eral pop u la tion. For ex am ple. This author has recently established an al gorithm for the treatment of paraphilias (24) that is based on an enhanced clas si fi ca tion of paraphilias de scribed in the DSM-III-R (23). which is quite con sis tent with Kinsey’s data. These agents ap pear to have a di rect im pact on sex ual drive. This would be in di cated in all cases of mild paraphilia. pedophilia. con sist ing of free and to tal tes tos ter one. then mild sa dism would also be highly prev a lent in the pop u la tion at large. which ulti mately re sults in an or gasm (23). In such a clinic. Level 5: The full antiandrogen treat ment or hor monal treat ment would be given intramuscularly (IM). com po nents of sexual drive and of nonparaphilic sexual behaviour. The last com po nent of the eval u a tion is phys i o log i cal test ing of sex ual arousal to establish whether a de vi ant sex ual pref er ence is pres ent or not. and the prev a lence of com pul sive sex ual be haviour is also un known. A typ i cal phar ma co log i cal re gime would be sertraline 200 mg daily with 50 mg of medroxyprogesterone acetate (MPA) or 50 mg of cyproterone ac e tate (CPA). prolactin. a state of sex ual arousal that pro vides mo ti va tion for seek ing out sex ual ac tiv ity. sex drive abnormalities and cer tain high-risk cases for sex ual vi o lence may in volve hor mone ab normalities. In the case of CSB. the ideal treat ment would re sult in a gen eral re duc tion of sex ual drive with out ex tin guish ing it—but giv ing the in di vid ual more con trol over his or her sex ual be hav iour. there is at least some ev idence that this might occur with the spe cific antiandrogen cyproterone ac e tate and the SSRI sertraline (24). At this time. the prev a lence of paraphilias in the gen eral pop u la tion is un known. spe cif i cally sex ual sa dism.8% of males were vic tims of child hood sex ual abuse (21). estradiol. as sum ing that the pres ence of rape fantasies indicates the presence of another paraphilia. This would in volve 50 to 300 mg of MPA daily or 50 to 300 mg of CPA daily. and the pres ence and ex tent of sub stance abuse. This would . As var i ous neu ro psy chi at ric prob lems can have a sig nif i cant effect on sexuality.

Greenberg and oth ers looked at a sample ( = 95) of paraphilic men treated with SSRIs com pared n with a control group ( n = 104) who received only The SSRIs The SSRIs have long been doc u mented as caus ing a re duc tion in sex ual de sire. het ero sex ual in ter course showed a slight in crease over the course of the study. in addition. and to a cer tain de gree.8 weeks). with a mi nor im pact on sex ual drive at Levels 2 and 3. The mean duration of treatment was 30. Sup pres sion of de vi ant sex ual fan ta sies. mod er ate. and de vi ant and nondeviant sex ual be hav iour. would be seen at Levels 3 and 4. to sup press de vi ant sexual urges and be hav iour. In gen eral. This indicated some improvement in normophilic behaviour. specifically sertraline. They have also been an im por tant ad vance in the treat ment of the paraphilias be cause they are well-known to the av er age psy chi a trist (15. such as ex hi bi tionism. Two sub jects dropped out. The fi nal sam ple (n = 58) showed that the 3 SSRIs were equal in their ef fec tiveness in re duc ing de vi ant sex ual fan ta sies. Kafka and Prentky completed an open-label outpatient study on one group of men with paraphilia and an other group suf fer ing from NPH. urges. Stein and oth ers reported a failure of treat ment of sex ual disor ders with fluoxetine hydrochloride (32). urges. where considerable clin i cal im prove ment was ob served (30). urges. Brad ford and oth ers re ported on a 12-week open-label dose study of pedophilia treated with sertraline (35). with a mod er ate re duc tion in sex ual drive. Significant reductions in sexual drive were observed. and fluvoxamine (36). treatment suc cesses for var i ous paraphilias. us ing fluoxetine hy dro chlo ride and sertraline. they could also be used for the treat ment of nonparaphilic hypersexuality. and be hav iour. a re duction in de vi ant sex ual fan ta sies. De creasing brain 5-HT in an i mals re sulted in sex ual drive in creases as mea sured by increased mounting behaviour. None of the patients dis con tin ued the sertraline due to in ad e quate treat ment re sponse. have been reported (25–36). and to re duce the risk of re cid i vism and further victimization. a mild. increasing brain levels of 5-HT reduced sex ual drive and sex ual behaviour. Physiological measures of sexual arousal showed deviant arousal was reduced. Suppression of de vi ant sex ual fan ta sies. Starting in 1990. The aims of treat ment us ing this al go rithm would be the suppres sion of de vi ant sex ual fan ta sies.1 mg daily.5 weeks (SD 16. Kafka re ported on 4 pa tients treated for NPH with fluoxetine hydrochloride (30). The mean ef fec tive dos age of sertraline was 131 mg daily. The study looked at var i ous sex ual be hav iours. and be hav iours (33). The mean dos age of sertraline in Kafka’s study was 100 mg daily. fluoxetine. These phar ma co log i cal treat ments are (24): · The spe cific se ro to nin reuptake in hib i tors (SSRIs) · The antiandrogens and hormonal treatments · The LHRH agonists most com monly used phar ma co log i cal agents for the treatment of the paraphilias and nonparaphilic hypersexuality. This reg i men would be used in se vere cases and some catastophic cases. In a sim i lar study. and for fluoxetine hy dro chlo ride it was 51. The principle ef fect was on de vi ant sex ual fan ta sies (36). mas tur ba tion. and se vere clas si fica tion would ap ply fol low ing the out line in DSM-III. Kafka re ported on an open-label clin i cal trial of men suf fering from paraphilia and NPH us ing sertraline (34). Pharmacological Treatment There are 3 main cat e go ries of phar ma co log i cal in ter ven tion in the paraphilias. There were 20 sub jects in the study. With regard to nonparaphilic hypersexuality (NPH). Clinical improvement in all cases was noted (31). urges. urges. Coleman and others com pleted a study of 13 men with paraphilia treated with fluoxetine hy dro chlo ride and re ported im prove ment in all aspects of de vi ant sex ual be hav iour but. the aims of phar ma co log i cal treat ments would be to sup press de vi ant sex ual fan ta sies. The treat ment nonresponders were of fered fluoxetine hy dro chlo ride. while at the s a m e t i m e . in clud ing sex ual arousal pat terns. The clin i cal re sponse rate was 50%. The subjects showed a significant reduction in deviant sex ual fan ta sies. c o m p a r a t i v e lev e l s of normophilic arousal—arousal to con sent ing sex with adults—was maintained or in fact in creased.30 The Ca na dian Jour nal of Psy chia try Vol 46. and behaviour. Level 6: A com plete sup pres sion of an dro gens and sex drive would be sought by giv ing CPA 200 to 400 mg IM weekly or pro vid ing a luteinizing hor mone–re leas ing hor mone (LHRH) ag o nist. and be hav iour. 25). No 1 in volve 300 mg of MPA given IM each week with 200 mg of CPA given IM ev ery 2 weeks. and a se vere re duc tion of sex ual drive (de pend ing on the dose of med i ca tion) would oc cur at Levels 4 and 5. but this would be dose-dependent. spe cif i cally. Greenberg and oth ers treated a variety of paraphilias using 3 different SSRIs. In contrast. This reg i men would be used for some se vere cases of paraphilia and would be the treatment of choice in cat astrophic cases. urges.25). Fluoxetine and sertraline have been the . A com plete or near-complete sup pres sion of sex ual drive would be seen at Level 6. He also reported on 3 cases of paraphilia treated with fluoxetine hydrochloride. and about 60% of this group showed some clin i cal improve ment. All of the de vi ant sex ual behaviours were reduced by the sertraline and. Both groups were treated over a 12-week pe riod with a mean dose of 30 mg fluoxetine hydrochloride daily. and be hav iours. There fore drugs that in crease 5-HT lev els in the brain have been used to treat paraphilias (15.

CPA also has strong progestational ac tiv ity. and sexual intercourse. Sev eral clin i cal stud ies have been com pleted (42-58). CPA is ac tive at an dro gen re cep tors through out the body. About 50% of the sub jects were also sex ual of fend ers. This would make them the drug of choice in the treat ment of paraphilias as well as nonparaphilic hypersexuality. re duc ing the lev els of FSH and LH. and behaviour. MPA has been used pri mar ily in open clinical tri als and most com monly is given IM at a dos age level of 300 to 400 mg weekly as part of an ini tial treat ment. The first clin i cal stud ies us ing CPA were con ducted in Germany (66. In the sec ond study. with the re duc tion to 100 mg weekly as part of a main te nance pro gram. MPA can be given both orally or IM. showed significant reduction in response to erotic stimuli. In 1971. CPA . This is partly due to stud ies started at Johns Hopkins. The sig nif i cant fea ture of this study is that it is the only one to ex am ine sys tem at i cally the ef fects of orally ad min is tered MPA. At the same time. In 80% of cases. They in cluded a con trol group of treat ment re fus ers who re ceived only group psy cho ther apy over the same pe riod. Wincze and oth ers com pleted a dou ble-blind study on 3 pedophiles using MPA (58). and no dou ble blind stud ies have been re ported. and feminization. a hyperinsulinic re sponse to a glu cose load.24). as well as sex ual sa dists. As a true antiandrogen. These stud ies pro vide ev i dence that SSRIs re duce deviant sexual fantasies. It blocks the intracellular mo lec u lar recep tors. They showed that MPA was an ef fec tive treat ment in re duc ing de vi ant sex ual fan ta sies and urges. spe cif i cally nau sea. Laschet and Laschet re ported on more than 100 sex u ally de vi ant men who were treated with CPA. They re ported a sig nif i cant reduc tion in de vi ant sex ual fan ta sies and pos i tive treat ment out come in all of these pa tients. The num ber of studies com pleted to date is still small. It is the acetate radical that gives it the progestinic effect. Clin i cal stud ies show that MPA has a sig nif icant im pact on de vi ant sex ual fan ta sies and de vi ant sex ual urges and be hav iour. Gottesman and Schu bert used a low dos age of MPA (60 mg daily) given orally for a pe riod of 15 months in an open-label trial in volv ing 7 sub jects (46). but has also been dic tated by the lack of al ter na tives such as CPA. Self-reported arousal out side of the lab o ra tory setting. urges. however. A num ber of side ef fects have been de scribed. Berlin and Mienecke treated 20 paraphilic men (42).February 2001 Treat ment of the Paraphilias and Com pul sive Sex ual Be hav iour 31 cognitive-behavioural treat ment (25). deep vein thrombosis. un pub lished ob ser va tions). Medroxyprogesterone acetate (Provera) has been the most com mon form of phar ma co log i cal treat ment for sex ual de vi ation in the US. weight gain. and feminization (37–41). In ad di tion. al though the mech a nism of ac tion is not fully un derstood (15). MPA is a progestagen and has a mo tive ac tion through the induc tion of tes tos ter one reductase in the liver. They noted that sexual arousal. Meyer and oth ers com pleted a study of 40 men treated with both MPA and group psy chother apy (49). in clud ing sex ual fan ta sies. Antiandrogens and Hor monal Agents The initial hormonal treatment for the paraphilias used estrogens. 24). nau sea or vomiting. Cyproterone ac e tate is a true antiandrogen as well as hav ing progestinic and antigonadotropic ef fects (15). The effectiveness of these treatments. head ache. and the po ten tial to ag gra vate or pre cip i tate di a be tes mellitus. It was orig i nally used in Ger many in the mid-1960s and since then has been used ex ten sively in var i ous parts of the world (59–71. however. Studies have shown that it does not com pete with androgens at the androgen receptor level and therefore by def i ni tion is not a true antiandrogen (15). the fre quency and se ver ity of sexually de vi ant fan ta sies and urges were sig nif i cantly reduced in the SSRI-treated group com pared with the con trol group. The MPA was given at a dosage of 400 mg weekly by IM in jec tions and the du ra tion of treat ment ranged from 6 months to 12 years. Cyproterone with out t h e a c e t a t e rad i cal has no antigonadotropic ef fects.67). Two open clin i cal stud ies of note were com pleted in 1981. how ever. In the first. He also extensively documented various side effects. hot flashes. de vi ant sex ual be hav iour. This study also as sessed treat ment out come. Nocturnal penile tu mes cence was also mea sured and was re duced in all cases with ac tive treat ment. was unreliable and inconsistent. The MPA-treated group had an 18% re cid i vism rate while the treat ment-refuser group had a 35% re cid i vism rate. vom it ing. and it also has an impact on erections. The dos age of MPA was 200 to 400 mg IM given weekly. de creased sperm pro duc tion. The block of an dro gen re cep tors de creases all types of sex ual be hav iour. Over the initial 12-week pe riod of treat ment. its ac tion as a progestagen blocks the se cre tion of the gon ado tro pins (FSH and LH). as measured by penile tumescence in a laboratory setting. This was an open-label clin i cal trial with a treat ment du ra tion of 6 months to 4 years (67). they ob served that there was a significant relapse rate if treat ment were dis con tin ued. 1984. mas tur ba tion. MPA can be given orally in dos ages rang ing from 50 to 300 mg daily (15. CPA is a com pet i tive in hib i tor of testosterone and dihydrotestosterone at an dro gen re cep tors through out the body (15. thereby de creasing cir cu lat ing lev els of tes tos ter one. Gagne treated 48 pa tients (45) and re ported effects similar to those of Berlin and Mienecke. as outlined above. was re duced be cause of their var i ous side ef fects. They were mostly ex hi bi tion ists and pedophiles. and Ortmann J. in clud ing weight gain. CPA is by far the most ex ten sively stud ied antiandrogen in terms of its effects as a treat ment for sex ual de vi a tion (15).

Kerbeshian J. There have been lim ited clinical studies on the use of LHRH agonists (72–75). CNS Spec trums 2000. 4. but they did not ap pear to respond. Com par a tive anal y sis of the roles of an dro gen in the feed back mech a nisms and sex ual be hav iour. The dou ble-blind cross over study used 19 sub jects. Liang T. Stein DJ. Hollender E. The role of se ro to nin reuptake in hib i tors in fo ren sic psy chi a try. Re view of Psy chi a try. ed i tors. There is ini tially an in crease in GRH se cre tion and then a re duc tion to al most zero. 1989. their com pliance was in ques tion. 10. ed i tors. Owens MJ. Neuropsychiatry of hypersexuality. In: Sadock BJ. Hu man Sex u al ity and its prob lems. Am J Hum Genet 1987. 5. Riba M. prin ci pally with high pretreatment re cidivism rates and a mean of 2. Hawkridge SM. They have the spe cific treatment ef fect of over stim u lat ing the hy po thal a mus. erec tions. Com pre hen sive Text book of Psychiatry. 16. The paraphilas. Cummings JL. Treat ment outcome was measured by questionnaires. CPA was also ad min is tered IM at levels of 300 mg every second week. 9. This sample also in cluded sex ual of fend ers. Chow TW. 11. 6. This dif fer en tial effect on sex ual arousal is a very im por tant clin i cal ob ser va tion that re quires fur ther re search. 12. An dro gen ac tion: Re cep tors and rapid re sponses. There was a re duc tion in sex ual arousal re sponses by ac tive drug treat ment that did not quite reach statistical sig nif i cance. Himelein CA. all of which show that CPA is gen er ally an ef fec tive treat ment for sex ual de vi a tion. Damassa DA(1997). Plasma testosterone levels fell to castration levels. LHRH Ag o nists Luteinizing hor mone–re leas ing hor mone agonists have also been used to treat paraphilias. Psychiatr Q 1999. 7th ed. J Clin Psy chi a try 1996. These treat ments are based on es tab lished neurobiological prin ci ples. and feminization were noted. A very im por tant study was published by Rosler and Witztum (73). Or ganic treat ments for the male sex ual of fender.60). Davidson JM. p 221–41. An dro gens and antiandrogens. p 77–89. Se ro to nin re cep tors and their func tion. in some cases.2:300–5.5 previ ous con vic tions for sex ual of fences per sub ject. Rowland CT. Liao S. Hung HC. There was a sig nif icant im pact on sex ual func tion ing com pared with a pre treatment phase. Brad ford JM. Sev eral other stud ies have since then been completed. 7. Phil adelphia: Lippincott Williams & Wilkins. how ever. Van Heerden B. Brad ford. ob ses sive com pul sive spec trum dis or der and the treat ment of sex u ally de vi ant be hav iour. in clud ing sexual fan ta sies and mas tur ba tion.75 mg of triptorelin and sup port ive psy cho ther apy for a fol low-up pe riod of be tween 8 and 42 months. one a dou ble-blind study and the other an examination of the sexual arousal patterns of pedophiles (59.32 The Ca na dian Jour nal of Psy chia try Vol 46. 14. Motta M.70:209–19. Vol ume 14. The Neuroscientist 1996. Stein DJ. A study by Rous seau and oth ers in 1998 doc u mented changes in sexual behaviour in prostate cancer patients treated with flutamide as well as an LHRH ag o nist. In the study of CPA ef fects on the sex ual arousal pat terns of pedophiles. An dro gens and antiandrogens. CNS Spec trums 2000. The neurobiology of ob ses sive–com pul sive dis or der. Conclusion There are sev eral phar ma co log i cal treat ments avail able for the treat ment of the paraphilias and nonparaphilic hypersexuality. Psychopharmacologic treat ments for nonparaphilic com pul sive sex ual be hav iours. The bi o log i cal ba sis of hu man sex u al ity. 20% of ex hi bi tion ists had a com plete elim i na tion of all de vi ant sex ual be hav iour and. Bris tol (UK): Tocris.57(Suppl 8): 3–6. Kafka M. Phil a del phia: Lippincott Wil liams & Wilkins. No 1 given orally at 100 mg daily and sig nif i cantly re duced sex ual drive. Side effects of weight gain. Hugo F. Neuropsychiatry: clin i cal as sess ment and ap proach to di ag no sis. ed i tor. p 12–145. Neuropeptides: bi ol ogy and reg u la tion. VII. 2000. In: Bancroft J. Com ings DE. Burd L. JMW. A con trolled study of Tourette syn drome. Can J Psy chi a try 1991. This was an un con trolled open study of 30 men with a mean age of 32 years who were treated with triptorelin. Phar ma co log i cal treat ment of the paraphilias. 24). P r o c e e d i n g s o f t h e 4 t h C o n gress o f E u r o p e a n C o l lege of . The pa tients were treated with triptorelin 3. there is no go nad o tro pin se cretion and the cir cu lat ing lev els of T and DHT drop to cas tra tion lev els (15. Chan KMB. 15. With this ap proach. Tourette syn drome and re cur rent paraphilic masturbatory fan tasy. Kwon JH. were all sig nif i cantly re duced by CPA. 1999. Broatch J. ed i tors. as was psychopathology as mea sured by var i ous writ ing styles. They re ceived monthly in jec tions of 3. ed i tors.75 mg IM monthly concurrently with CPA 200 mg daily for 5 months. Com pre hen sive Text book of Psy chi a try. p 755–78. Behav Sci Law 1985. prin ci pally pedophilia. 1977. Laschet and Laschet re ported on a sim i lar study on 300 men treated for up to 8 years with ex cel lent treat ment out come (66). In 5 out of the 6 pa tients. This au thor com pleted 2 stud ies on CPA. 1995.3:355–75. Tymoczko JL. All of these men showed a de crease in de vi ant sex ual fan ta sies and de vi ant sexual urges. ed i tors. Hypersexuality should be in cluded as a sep a rate sex ual dys func tion (sex ual de sire disor der) in DSM-V. Oosthuizen P. 7th Edi tion. In: Oldham JM. Motta M. Stein DJ. The LHRH agonists are given IM and have a pro longed ac tion. New York: Ra ven Press. 2. New York: Ra ven Press. p 137–149. 8. JMW.5:49–59. Fu ture re search on se ro to nin recep tors and polypeptidic neurotransmitters is likely to lead to new phar ma co log i cal treat ments.5:36–46. Thibaut and oth ers re ported on the treat ment of 6 men who suf fered from a paraphilia. all of whom met DSM-III-R cri te ria for pedophilia. 3. and or gasms. Other mea sures of sex ual behav iour. Self-reported urges of sex ual arousal were all reduced. Nemeroff CB. p 60–71. Sadock VA. Two of them had pre vi ously been treated with oral CPA at dos ages rang ing from 150 to 300 mg daily. these be haviours did not re turn even af ter the treat ment was dis con tin ued. They were first flagged as po ten tial treat ment by this au thor in 1985 (14).41:839–66.36:155–7. sum mary: a com mon ge netic dis or der caus ing disinhibition of the limbic sys tem. References 1. it was noted that de vi ant sex ual arousal was af fected differ ently from normophilic arousal in the same sub jects. Bancroft J. Smith ER. In: Mar tini L. Ed in burgh: Chur chill Living stone. Brad ford JMW. CPA was ad minis tered orally in 3-month ac tive-treatment phases al ter nat ing with 3-month pla cebo phases. Con se quently. In: Mar tini L. a marked de crease in sex ual be hav iour was noted (75). Brad ford. 1999. Sadock VA. Bissette G. Ob sessive-compulsive and spec trum dis or der: over view and qual ity of life is sues. 13. 1977. Wash ing ton (DC): Amer i can Psy chi at ric Press. depression. In: Sadock BJ. Kennet GA.

9:1–13. Brad ford JMW. The treat ment of sex ual of fend ers. Antiandrogen (cyproterone ac e tate) ther apy in de vi ant hypersexuality. Cou ture M. Wiedeking C. A sin gle case study. Car ci noma of the breast in trans sex ual in di vid u als af ter sur gi cal and hor monal in ter fer ence with pri mary and sec ond ary sex char ac ter is tics. 1990.53:267–71. Sa dis tic ho mo sex ual pedophilia: Treat ment with cyproterone ac e tate. Sandhu S. Neumann. sex ual ad dic tions and paraphilias. 58.. Greenberg DM. Kafka. Bansal S.6:821–6. 42. 39. 23. 2:159–63. Phar ma col ogy and po ten tial use of cyproterone ac e tate. Sex ual Dis ord ers.2:547–9. 54. Walker P.158:844–7. A dou ble-blind pla cebo con trolled trial of medroxyprogesterone ac e tate and cyproterone ac e tate with seven pedophiles. Cor doba OA. Phil a del phia: Saunders. p 281. Brad ford JMW. 68. 44. Kuhn JM. Am J Psy chi a try 1991. Golla FL. Sertraline pharmacotherapy for paraphilias and paraphilia-related diso r ders: an open trial. Fallon BA. Perilstein RD. Southren AL. Treat ment of sex of fend ers with antiandrogenic med i cation: con cep tu al iza tion. Samimi F.37:248-57. The treat ment of sex ual of fend ers. Hoffet H. Oes tro gens and psychosexual dis or ders. Paraphilias. XY and 47. SM. Money J. 47. ed i tor. 57.6:165–72. En do cri nol ogy and hu man be hav ior. Int J Law Psy chi a try 1980. Greenberg DM.4:99–104. Coo per AJ. Br J Psy chi a try 1972. An der son C.52:169–70. 1987.140:1036–9. XY males with an ti so cial and/or sex-offending be hav ior: Antiandrogen ther apy plus coun sel ing. Florida. ed i tor. Monte Carlo. Compr Psy chi a try 1981. 37. Davies TD.February 2001 Treat ment of the Paraphilias and Com pul sive Sex ual Be hav iour 33 Neuropsychopharmacology: The Role of Se ro to nin in Psy chi at ric Ill ness. 27. Pawlak A. Psychoneuroendocrinology 1975. 28. Ef fect of com bined andro gen block ade with an LHRH ag o nist and flutamide in one se vere case of male ex hi bi tion ism. Psychopharmacotherapy of sex of fend ers with cyproterone ac e tate. The paraphilias: a mul ti plic ity of de vi ant beh av iours. 66. 51.9:287–92. Meinecke CF. Benjamin. Meyer W. Can J Psy chi a try 1992. Gagne P. Fol low up of 11 XYY males with im pul sive and/or sex-offending be hav ior. In: Michael R. Acta Psychiatr Scand 1993. Psychol Med 1979. 40. Fluoxetine treat ment of a fe tish (let ter). J Int Med Res 1974. Schering sym po sium uber sex ual deviationen und ihre medikamentose Behandlung.52:436–7. Arch Sex Behav 1986. Cordier B. . Wash ing ton (DC): Amer i can Psy chi at ric As so ci a tion.35:338–41. An nals of Clin i cal Psy chi a try 1994. J Clin Psy chi a try 1992.37:567–9. 30. 47. Coo per AJ. 53. 26. Losztyn S. Walker PA. Treat ment of sex of fend ers with Depo-provera.148:950. provera and sex of ther a pist in the treatment of gen i tal ex hi bi tion ism. po tency and testicular func tion.24:525–32. Emory LE. Mothes C. 19. Pawlak A. Bull Am Acad Psy chia try Law 1990. Arch Sex Behav 1980. Jour nal of Ste roid Bio chem is try 1975. 24. 43. Crepault C. Med Sci Law 1973. Wiedeking C. 6 2. Kafka MP. BMJ 1968. Com bined antiandrogen and coun sel ing pro gram for treat ment of 46. 3rd ed rev. Zohar J. Jour nal of Sex Re search 2000.338:464–5.87:445–50. Brit ish Jour nal of Psy chi a try 1991. 75.22:458–64. Money J. An ex plor atory study of the role of psychotropic med i ca tions in treat ment of sex ual of fend ers. Fertil Steril 1985. MP. Ef fect of a long-lasting gonadotrophin hor mone-releasing hor mone ag o nist in sex cases of se vere male paraphilia. Serotonergic med i ca tions for sex ual ob ses sions. J Clin Psy chi a try 1991. 56. A com par i son of treat ment o f paraphilias with three se ro to nin reuptake in hib i tors: a ret ro spec tive study. Ott F. 1976. p 175–93. Motta M. Altman K. Newman S. The na ture and ex tent of sex ual as sault. Wincze WP. Phanjoo AL. Dickey R. Dupont A.1:1006–7.1:165–78. Money J. 22. Walker PA. Di ag nos tic and Sta tis ti cal Man ual of Men tal Dis or ders. Am J Psy chi a try 1983. Greenberg D.120:59–63.138:644–6. 52. Amer i can Psy chi at ric As so ci a tion Meet ing. Dwyer. p 105–20. Stein DJ. Symmers WSC. met a bolic and hor monal ef fects on men of long-term ther apy with medroxyprogesterone ac e tate. Arch Sex Behav 1993. p 169.15:293–305. 70. Moore AM. Vittek J. Three cases of paraphilias re spon sive to fluoxetine treat ment. Meyer WJ. Hucker S. A pla cebo con trolled study of the antiandrogen cyproterone ac e tate in de vi ant hypersexuality. New York: Ple num Press. Ortmann J. An dro gens and antiandrogens. Laschet U.9:565–81. Sex ual Abuse: A Jour nal of Re search and Treat ment 1997. Cyproterone ac e tate for male hypersexuality. Fried man LJ. Lorefice LS. Jour nal of Of fender Reh a bil i ta tion 1992. Lon don: Ox ford Uni versity Press. Money J. 46. 36. Pawlak A. Life Sciences Monograph 1971. 41.22:383–402. Ismail AA. Cha pel JL. In ter na tional Psy chi a try Clinics 1972. Pope S. 53:351–8. 74. Rosler A. Boulet J. J Clin Psy chi a try 1992. Weiedeking C. Dis cus sion of the hor monal in hi bi tion of li bido in male sex of fend ers. Langevin R. Chap ter 6: Oc cur rences in the Pop ula tion. J. Rou leau JL. 1977. Can J Psy chi a try 1992. Abel GG. Laschet L. 1995 May 24. Paitich D. Can J Psy chi a try 1992. Treat ment of the paraphilic dis or ders: A re view of the role of the se lec tive se ro to nin reuptake in hib i tors. Sex ual Of fences Against Children. New York: Ra ven Press. Brad ford JMW.2:3–85. Ef fects of cyproterone ac e tate on sex ual arousal pat terns of pedophiles. & Malamud M. 37:104–8. F. Phys i cal. 73. Money JM. Migeon C. Emory E. Pawlak A. 32. ed i tors. J Clin Psy chi a try 1991. Gojer J. p 263–79. XYY and 46. The Kinsey data: mar ginal tab u la tions of the 1938-1963 in ter views con ducted by the In sti tute for Sex Re search.43:102–9. Kiersch TA. Lan cet 1949. 45. 71.13:195–6.2:65. Ufer J. Fluoxetine treat ment of voy eur ism. be hav ior and psychopathology.138:601–7. Gottesman HG. Vol ume 1. Whittaker LH. 18. Com pul sive ex hi bi tion ism suc cess fully treated with fluvoxamine: a con trolled case study.18:75–88. 33. Brad ford JMW. Treat ment of men with paraphilia with a long act ing an a logue of go nad o tro pin. Ef fect of progestagens on an dro gen me tab o lism. In: Sachar E. 59. Depo provera treat ment for sex of fend ing be hav ior: An eval u a tion of out come. Brad ford JMW. 25. The ef fects of cyproterone ac e tate on sleep ing and wak ing penile erec tions in pedophiles: Pos si ble im pli ca tions for treat ment. Hodge SR. 1979. Mo naco. 50. J Nerv Ment Dis 1994. Brad ford JMW. cas tra tion and antihormone ther apy. Col lier C. 17. Brad ford JMW. Liebowitz MR.37:33–9. Arch Sex Behav 1993. Foote RM. Em man uel NP. Kaplan Z. 34. Geller G. Lehnert J. The treat ment of sex ual de vi a tion us ing a phar ma co log i cal app roach. Kafka MP. J Clin Psy chi a try 1994. Laschet U.18:179–87. Treat ment of sex of fend ers with medroxyprogesterone ac e tate. 49. Bull Am Acad Psy chi a try Law 1996. The ther a peu tic use of an dro gen-depleting hor mone. John son AB. An thony DT. Hor mone treat ment of sex ual of fend ers. Ot tawa: Ca na dian Gov ern ment Pub lishing Cen tre. (1997). Ramsay G.37:687–93. New York: Ra ven Press. 29. Men’s erotic fan ta sies. N Engl J Med 1998.8:165–74. Suc cess ful treat ment of paraphilic co er cive dis or der (a rap ist) with fluoxetine hy dro chlo ride.99:928–35. 48. ed i tors. 67. Medroxyprogesterone ac e tate antiandrogen treat ment of hypersexuality in a paedophiliac sex of fender.6:189–95. Labrie F & Cou ture N. Field H. Jour nal of Sex Re search 1970. Medl J Aust 1959. N Engl J Med 1998. Prentky R. Am J Psychi a try 1981. Thibaut F. Pharmakopsychiatrie Neuropsychopharmakologic 1971. Schweiz Med Wochschr 1968. Fluoxetine treat ment of non-paraphilic sex ual ad dic tions and paraphilias in men. Goldberg M. Borgaonkar D. Treat ment of men with paraphilia.54:182–8. Martindale JJ.20:249–59. 72. Gebhard PH. Gordon GG. Rous seau LR. New Re search Pro gram Ab stracts NR 441.re leas ing hor mone. Can J Psy chi a try 1987. 61. XYY sex of fend ers. 38. 1994. Berlin FS. 55.32:22–31. In: Mar shall WL. Bull Am Acad Psy chi a try Law 1992. Barbaree HL. Low-dose oral medroxyprogesterone ac e tate in the man age ment of the paraphilias. Laschet L. Coo per AJ. Witztum E. Horm Metab Res 1997. 63. Curry S. p 9–20. Hol lander E. Ef fects of medroxyprogesterone ac e tate on sub jec tive arousal. Brad ford JMW. The man age ment of a case of treat ment-resistant paraphilia with a long-acting LHRH ag o nist. Cou ture M. 64. The in flu ence of antiandrogens on li bido. Schnei der FR.22:629–41. Walker PJ. Dou ble-blind pla cebo cross over study of cyproterone ac e tate in the treat ment of the paraphilias. arousal to erotic stim u la tion and noc tur nal penile tu mes cence in male sex of fend ers. J Behav Ther Exp Psy chi a try 1979. Maimi. Cesnik J. re view of treat ment mo dal i ties and pre lim i nary find ings. 65. 35. The ef fect of as ser tive ness train ing. 21. 9:349–61. Hand book of Sex ual As sault.3:443–51. O’Rourke A. In: Mar tini L. Can J Psy chi a try 1992. Cernovovsky Z. Brad ford JMW. Schu bert DS. Laws DR. Love DL. 1991. Meyer WJ.55:86–8. Antiandrogens in the treat ment of sex ual de vi a tions of men. Sertraline in the treat ment of pedophilia: an open la bel study.338:416–65. Diethyl stil boes trol in the man age ment of psychopathological states in males. Smith C. Lydiard RB. Coo per AJ. Ballenger JC. Money J.10:275–82. Am J Psy chi a try 1981. Gain D. Use of an dro gen de plet ing hor mone in the treat ment of male sex of fend ers. 60. J Clin Psy chi a try 1993. 69. 20. Hor mones. 1968. Coleman E. Can J Psy chi a try l990.98:1812. 31. Lipper S.

On y présente aussi certaines orientations futures de la recherche en traitement pharmacologique. No 1 Résumé—La neu ro bio lo gie. Les études indiquent que divers agents pharmacologiques. dans la catégorie des troubles du désir sexuel. On ne comprend pas encore complètement la neurobiologie des troubles sexuels.34 The Ca na dian Jour nal of Psy chia try Vol 46. En outre. on devrait spécifier si les paraphilies sont « avec hypersexualité » ou « sans hypersexualité ». les antiandrogènes. la neu ro phar ma colo gie et le traite ment phar ma colo gique des paraphil ies et du com por te ment sexuel com pul sif Ces dernières années. Les modes d’action. les agonistes LHRH et d’autres réduisent le désir sexuel. les cibles du trai ement et les méthodes usuelles t de prescription de ces agents sont recensés dans cet article. on constate un intérêt accru pour le traitement des troubles sexuels. les récepteurs et les hormones responsables du désir sexuel. Les dysfonctions sexuelles sont non déviantes ou non paraphiliques. . Les troubles sexuels sont classés dans le Manuel diagnostique et statistique des troubles mentaux (DSM IV) comme étant les dysfonctions sexuelles. Un algorithme pour l’utilisation de ces médicaments dans letraitement des paraphilies et de l’hypersexualité non paraphilique est présenté. bien que la neuroanatomie fonctionnelle et la recherche neuropharmacologique aient exposé les neurotransmetteurs. les dosages. les paraphilies et les troubles de l’identité sexuelle. y compris les inhibiteurs de recaptage de la sérotonine (IRS). Les dysfonctions sexuelles devraient inclure « le trouble du désir sexuel hyperactif ».

February 2001 35 .

No 1 .36 The Ca na dian Jour nal of Psy chia try Vol 46.

February 2001 37 .

38 The Ca na dian Jour nal of Psy chia try Vol 46. No 1 .

Sign up to vote on this title
UsefulNot useful